Regulatory News:
Aerocrine (STO:AERO-B):
Continued growth of US clinical sales in the third quarter (+42%) and volume of tests (+81%).
January – September 2013
· Global Net sales decreased by 9% to SEK 100.5m (110.8)*. Adjusted for currency fluctuations, net sales decreased by 6% Year over Year (Y-o-Y).
Help employers find you! Check out all the jobs and post your resume.
